Home

Burden

Read time: 4 min

Early intervention and re-assessment are essential to optimize outcomes for patients with major depressive disorder

Early intervention and treatment adjustment as necessary to provide complete symptomatic relief and...

Read time: 3 min

Satellite symposium

Assessing patient disability is vital for successful treatment of migraine

When measuring the success of migraine treatment, it is easy to focus on clinical features like...

How migraine can impact a person’s life when they are experiencing a migraine attack

At EAN 2022, Cristina Tassorelli, Professor of Neurology, University of Pavia, Italy, discussed how...

Read time: 4 min

Satellite symposium

Experts’ perspectives on managing chronic migraine in their own clinical practice

Three experts from different countries provided perspectives on their own clinical practice...

Read time: 2 min

Congress highlights

Raising the healthcare prioritization of headache: Why and how?

Headache is the most common neurologic disorder but the least acknowledged, said Professor Rigmor...

Read time: 2 min

Satellite symposium

What can be done to lower the economic cost of migraine?

The annual economic cost of migraine is high — estimated to be €50–111 billion in...

Read time: 3 min

Congress highlights

How do psychiatric comorbidities affect migraine and its treatment?

Patients with migraine often have psychiatric comorbidities. This can affect disease severity and...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country